Diabetes Management for the Nephrology Care Team: New Technology and New Drugs

Online Product

This program brings together members of the nephrology care team to discuss the cutting edge of rapidly advancing diabetes technologies and treatments. Diabetes is the most common cause of CKD and kidney failure requiring dialysis or kidney transplantation. Continuous glucose monitoring (CGM), insulin pumps, and closed-loop technology (automated insulin delivery [AID]) have revolutionized diabetes care. New drug classes are also available to treat diabetes and reduce CKD-related complications, including progression to kidney failure and cardiovascular disease. Nephrology care teams are well positioned to help implement new diabetes treatments according to current guidelines. Nephrology care teams often assume comprehensive care for patients with complex disease, including those with advanced CKD, kidney failure, and kidney transplants. Since many of these patients have diabetes, optimal diabetes management is an important part of their care. Given the presentation of type 1 diabetes in adults and type 2 diabetes in the pediatric population and the discovery of atypical forms of diabetes, correct diabetes classification is imperative because the treatment strategies differ depending on the etiology. Please note: no CE credit is available for this On-Demand product.